DocMorris AG (DOCM.SW)
DocMorris AG operates in the Medical - Distribution industry of the Healthcare sector, headquartered in Frauenfeld, TH, CH. The stock last traded at $9.46, up 1.12% on the session, giving a market capitalisation of $462.5M. Its beta of 1.86 implies it has historically moved more than the broad market.
DocMorris AG is a key player in the pharmaceutical sector, focusing on both online pharmacy services and the wholesale supply of medical and pharmaceutical goods. The company provides a comprehensive selection of items, including prescription and over-the-counter medications, health and wellness products, beauty and personal care lines, dietary supplements, pain relief remedies, and emergency first aid supplies. Furthermore, it offers specialized medication management support. In addition to its significant digital footprint, DocMorris AG also operates traditional brick-and-mortar pharmacy locations. Its commercial activities extend across Switzerland and into various international territories, serving medical practitioners, other online pharmaceutical distributors, and individual consumers directly. Notable brands within its portfolio include Zur Rose, PromoFarma, TeleClinic, and DocMorris. Established in 1993 and based in Frauenfeld, Switzerland, the company adopted its current name, DocMorris AG, in May 2023, having previously been known as Zur Rose Group AG.
DocMorris AG is most often compared with the following Healthcare names: